259 related articles for article (PubMed ID: 19053302)
1. A new PEG-beta-alanine active derivative for releasable protein conjugation.
Pasut G; Mero A; Caboi F; Scaramuzza S; Sollai L; Veronese FM
Bioconjug Chem; 2008 Dec; 19(12):2427-31. PubMed ID: 19053302
[TBL] [Abstract][Full Text] [Related]
2. Site-specific pegylation of G-CSF by reversible denaturation.
Veronese FM; Mero A; Caboi F; Sergi M; Marongiu C; Pasut G
Bioconjug Chem; 2007; 18(6):1824-30. PubMed ID: 17941684
[TBL] [Abstract][Full Text] [Related]
3. In situ growth of side-chain PEG polymers from functionalized human growth hormone-a new technique for preparation of enhanced protein-polymer conjugates.
Magnusson JP; Bersani S; Salmaso S; Alexander C; Caliceti P
Bioconjug Chem; 2010 Apr; 21(4):671-8. PubMed ID: 20201488
[TBL] [Abstract][Full Text] [Related]
4. Extended activity in cynomolgus monkeys of a granulocyte colony-stimulating factor mutein conjugated with high molecular weight polyethylene glycol.
Eliason JF; Greway A; Tare N; Inoue T; Bowen S; Dar M; Yamasaki M; Okabe M; Horii I
Stem Cells; 2000; 18(1):40-5. PubMed ID: 10661570
[TBL] [Abstract][Full Text] [Related]
5. Site-specific PEGylation for high-yield preparation of Lys(21)-amine PEGylated growth hormone-releasing factor (GRF) (1-29) using a GRF(1-29) derivative FMOC-protected at Tyr(1) and Lys(12).
Youn YS; Lee KC
Bioconjug Chem; 2007; 18(2):500-6. PubMed ID: 17243755
[TBL] [Abstract][Full Text] [Related]
6. Phenyl amide linker improves the pharmacokinetics and pharmacodynamics of N-terminally mono-PEGylated human growth hormone.
Wu L; Ji S; Shen L; Hu T
Mol Pharm; 2014 Sep; 11(9):3080-9. PubMed ID: 25115329
[TBL] [Abstract][Full Text] [Related]
7. Reversible PEGylation: a novel technology to release native interferon alpha2 over a prolonged time period.
Peleg-Shulman T; Tsubery H; Mironchik M; Fridkin M; Schreiber G; Shechter Y
J Med Chem; 2004 Sep; 47(20):4897-904. PubMed ID: 15369394
[TBL] [Abstract][Full Text] [Related]
8. Chemical and Enzymatic Site Specific PEGylation of hGH: The Stability and in vivo Activity of PEG-N-Terminal-hGH and PEG-Gln141-hGH Conjugates.
Grigoletto A; Mero A; Zanusso I; Schiavon O; Pasut G
Macromol Biosci; 2016 Jan; 16(1):50-6. PubMed ID: 26350165
[TBL] [Abstract][Full Text] [Related]
9. Chemical and enzymatic site specific PEGylation of hGH.
da Silva Freitas D; Mero A; Pasut G
Bioconjug Chem; 2013 Mar; 24(3):456-63. PubMed ID: 23432141
[TBL] [Abstract][Full Text] [Related]
10. In vivo efficacy of recombinant methioninase is enhanced by the combination of polyethylene glycol conjugation and pyridoxal 5'-phosphate supplementation.
Sun X; Yang Z; Li S; Tan Y; Zhang N; Wang X; Yagi S; Yoshioka T; Takimoto A; Mitsushima K; Suginaka A; Frenkel EP; Hoffman RM
Cancer Res; 2003 Dec; 63(23):8377-83. PubMed ID: 14678999
[TBL] [Abstract][Full Text] [Related]
11. Tailored PEG for rh-G-CSF analogue site-specific conjugation.
Salmaso S; Bersani S; Scomparin A; Mastrotto F; Scherpfer R; Tonon G; Caliceti P
Bioconjug Chem; 2009 Jun; 20(6):1179-85. PubMed ID: 19469471
[TBL] [Abstract][Full Text] [Related]
12. Self-assembling nanocomposites for protein delivery: supramolecular interactions between PEG-cholane and rh-G-CSF.
Salmaso S; Bersani S; Mastrotto F; Tonon G; Schrepfer R; Genovese S; Caliceti P
J Control Release; 2012 Aug; 162(1):176-84. PubMed ID: 22727711
[TBL] [Abstract][Full Text] [Related]
13. Protein carboxyl amidation increases the potential extent of protein polyethylene glycol conjugation.
Li S; Yang Z; Sun X; Tan Y; Yagi S; Hoffman RM
Anal Biochem; 2004 Jul; 330(2):264-71. PubMed ID: 15203332
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic/pharmacodynamic (PK/PD) differentiation of native and PEGylated recombinant human growth hormone (rhGH and PEG-rhGH) in the rat model of osteoarthritis.
Nemirovskiy O; Zheng YJ; Tung D; Korniski B; Settle S; Skepner A; Yates M; Aggarwal P; Sunyer T; Aguiar DJ
Xenobiotica; 2010 Aug; 40(8):586-92. PubMed ID: 20509748
[TBL] [Abstract][Full Text] [Related]
15. Effect of divalent polyethylene glycol units, conjugated on human granulocyte colony-stimulating factor, on biological activities in vitro and in vivo.
Yamasaki M; Asano M; Yokoo Y; Okabe M
Drugs Exp Clin Res; 1998; 24(4):191-6. PubMed ID: 10051965
[TBL] [Abstract][Full Text] [Related]
16. Prolonged circulation and in vivo efficacy of recombinant human granulocyte colony-stimulating factor encapsulated in polymeric micelles.
Harada M; Ohuchi M; Hayashi T; Kato Y
J Control Release; 2011 Nov; 156(1):101-8. PubMed ID: 21723892
[TBL] [Abstract][Full Text] [Related]
17. Site-specific PEGylation of protein disulfide bonds using a three-carbon bridge.
Balan S; Choi JW; Godwin A; Teo I; Laborde CM; Heidelberger S; Zloh M; Shaunak S; Brocchini S
Bioconjug Chem; 2007; 18(1):61-76. PubMed ID: 17226958
[TBL] [Abstract][Full Text] [Related]
18. Site-directed enzymatic PEGylation of the human granulocyte colony-stimulating factor.
Maullu C; Raimondo D; Caboi F; Giorgetti A; Sergi M; Valentini M; Tonon G; Tramontano A
FEBS J; 2009 Nov; 276(22):6741-50. PubMed ID: 19843182
[TBL] [Abstract][Full Text] [Related]
19. Efficient preparation and PEGylation of recombinant human non-glycosylated erythropoietin expressed as inclusion body in E. coli.
Wang YJ; Liu YD; Chen J; Hao SJ; Hu T; Ma GH; Su ZG
Int J Pharm; 2010 Feb; 386(1-2):156-64. PubMed ID: 19932158
[TBL] [Abstract][Full Text] [Related]
20. Reversible pegylation prolongs the hypotensive effect of atrial natriuretic peptide.
Nesher M; Vachutinsky Y; Fridkin G; Schwarz Y; Sasson K; Fridkin M; Shechter Y; Lichtstein D
Bioconjug Chem; 2008 Jan; 19(1):342-8. PubMed ID: 18069777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
